Quick Answer
ENvue Medical, Inc. reported Revenue (ASC 606) of $2.56 million for fiscal year 2024.
ENvue Medical, Inc. Revenue (ASC 606) — Annual History
| Fiscal Year | Revenue (ASC 606) | YoY Change |
|---|---|---|
| 2024 | $2.56M | +12.0% |
| 2023 | $2.28M | +203.6% |
| 2022 | $752.0K | -55.6% |
| 2021 | $1.70M | +172.1% |
| 2020 | $623.0K | +17.5% |
| 2019 | $530.0K | +66.7% |
| 2018 | $318.0K | — |
Quarterly Revenue (ASC 606)
| Quarter Ending | Revenue (ASC 606) | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $722.0K | +92.0% | +46.2% |
| June 30, 2025 | $494.0K | -39.5% | -51.8% |
| March 31, 2025 | $1.02M | +11.3% | +172.6% |
| September 30, 2024 | $376.0K | -17.9% | -54.0% |
| June 30, 2024 | $817.0K | +177.9% | -11.3% |
| March 31, 2024 | $921.0K | +160.2% | +101.1% |
| September 30, 2023 | $458.0K | +372.2% | +55.8% |
| June 30, 2023 | $294.0K | -39.4% | -16.9% |
- ENvue Medical, Inc. showed an increase of +12.0% in Revenue (ASC 606) compared to the prior fiscal year.
- Over the 2018–2024 period, ENvue Medical, Inc.’s revenue (asc 606) has grown by 704.4% (from $318.0 thousand to $2.56 million).
- The most recent figure is from ENvue Medical, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 31, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: